Evaluation of various culture media for detection of rapidly growing mycobacteria from patients with cystic fibrosis

Journal of Clinical Microbiology

Volumn 54, Issue 7, 2016, Pages 1797-1803

  Preece, Clair L ^a,b   Wichelhaus, Thomas A ^c   Perry, Audrey ^a   Jones, Amanda L ^b   Cummings, Stephen P ^b   Perry, John D ^a,b   Hogardt, Michael ^c  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NORTHUMBRIA UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CULTURE MEDIUM;

AGAR MEDIUM; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; DISEASE ASSOCIATION; GROWTH RATE; HUMAN; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; RAPIDLY GROWING MYCOBACTERIA; SPECIES COMPARISON; SPUTUM ANALYSIS; ADULT; CHEMISTRY; CHILD; COMPARATIVE STUDY; COMPLICATION; EVALUATION STUDY; FEMALE; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PRESCHOOL CHILD; PROCEDURES; SPUTUM;

ADULT; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; SPUTUM;

EID: 84976401907     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00471-16     Document Type: Article

References (25)

1. Cystic Fibrosis Trust. 2010. Laboratory standards for processing microbiological samples from people with cystic fibrosis: report of theUKCystic Fibrosis Trust Microbiology Laboratory Standards Working Group. Cystic Fibrosis Trust, Bromley, United Kingdom.
2. Brown-Elliot BA, Wallace RJ. 2011. Mycobacterium: clinical and laboratory characteristics of rapidly-growing mycobacteria, p 525-538. In Versalovic J, Carroll KC, Jorgensen JH, Funke G, Landry ML, Warnock DW(ed), Manual of clinical microbiology, 10th ed. ASM Press, Washington, D.C.
3. Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, Hansen CR, Finstad PL, Pressler T, Høiby N, Katzenstein TL. 2015. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros 14:46-52. http://dx. doi. org/10. 1016/j. jcf. 2014. 08. 002.
4. Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL, Herrmann JL. 2009. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 47:4124-4128. http://dx. doi. org/10. 1128/JCM. 01257-09.
5. Seddon P, Fidler K, Raman S, Wyatt H, Ruiz G, Elston C, Perrin F, Gyi K, Bilton D, Drobniewski F, Newport M. 2013. Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis 19:1128-1130. http://dx. doi. org/10. 3201/eid/1907.120615.
6. Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, Hananya S, Blau H. 2015. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros 14:53-62. http://dx. doi. org/10. 1016/j. jcf. 2014. 05. 008.
7. Martiniano SL, Nick JA, Daley CL. 2016. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 37:83-96. http://dx. doi. org/10.1016/j. ccm. 2014. 11. 003.
8. Burns JL, Rolain JM. 2014. Culture-based diagnostic microbiology in cystic fibrosis: can we simplify the complexity? J Cyst Fibros 13:1-9. http://dx. doi. org/10. 1016/j. jcf. 2013. 09. 004.
9. Whittier S, Hopfer RL, Knowles MR, Gilligan PH. 1993. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 31:861-864.
10. Esther CR, Jr, Hoberman S, Fine J, Allen S, Culbreath K, Rodino K, Kerr A, Gilligan P. 2011. Detection of rapidly-growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol 49:1421-1425. http://dx. doi. org/10. 1128/JCM. 02379-10.
11. Middlebrook G, Cohn ML. 1958. Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health 48:844-853. http://dx. doi.org/10. 2105/AJPH. 48. 7. 844.
12. Blauwendraat C, Dixon GL, Hartley JC, Foweraker J, Harris KA. 2012. The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. Eur J Clin Microbiol Infect Dis 31:1847-1853. http://dx. doi. org/10. 1007/s10096-011-1510-9.
13. De Soyza A, Hall AJ, Mahenthiralingam E, Drevinek P, Kaca W, Drulis-Kawa Z, Stoitsova SR, Toth V, Coenye T, Zlosnik JE, Burns JL, Sa-Correia I, De Vos D, Pirnay JP, Kidd TJ, Reid D, Manos J, Klockgether J, Wiehlmann L, Tummler B, McClean S, Winstanley C. 2013. Developing an international Pseudomonas aeruginosa reference panel. Microbiologyopen 2:1010-1023. http://dx. doi. org/10. 1002/mbo3. 141.
14. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38:910-913.
15. Coenye T, Vandamme P, LiPuma JJ, Govan JR, Mahenthiralingam E. 2003. Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol 41:2797-2798. http://dx. doi. org/10. 1128/JCM. 41. 6. 2797-2798. 2003.
16. Vermis K, Coenye T, LiPuma JJ, Mahenthiralingam E, Nelis HJ, Vandamme P. 2004. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int J Syst Evol Microbiol 54:689-691. http://dx. doi. org/10. 1099/ijs. 0. 02888-0.
17. Richter E, Niemann S, Rüsch-Gerdes S, Hoffner S. 1999. Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques. J Clin Microbiol 37:964-970.
18. Preece CL, Perry A, Gray B, Kenna DT, Jones AL, Cummings SP, Robb A, Thomas MF, Brodlie M, O'Brien CJ, Bourke SJ, Perry JD. 2016. A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis. J Cyst Fibros 15:186-191. http://dx. doi. org/10. 1016/j. jcf. 2015. 05. 002.
19. Gilligan PH, Gage PA, Bradshaw LM, Schidlow DV, DeCicco BT. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 22:5-8.
20. Welch DF, Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PA, Hilman BC, Chartrand SA. 1987. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol 25:1730-1734.
21. Henry DA, Campbell ME, LiPuma JJ, Speert DP. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 35:614-619.
22. Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D. 1999. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 37:1004-1007.
23. Verregghen M, Heijerman HG, Reijers M, van Ingen J, van der Ent CK. 2012. Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients: a case-control study. J Cyst Fibros 11:340-343. http://dx. doi. org/10. 1016/j. jcf. 2012. 01. 006.
24. Esther CR, Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. 2010. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9:117-123. http://dx. doi. org/10. 1016/j. jcf.2009. 12. 001.
25. Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, Hempstead SE, Koetz K, Sabadosa KA, Sermet-Gaudelus I, Smyth AR, van Ingen J, Wallace RJ, Winthrop KL, Marshall BC, Haworth CS. 2016. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary. Thorax 71:88-90.